Literature DB >> 11479175

Complement and renal ischemia-reperfusion injury.

J V Bonventre1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11479175     DOI： 10.1053/ajkd.2001.26113

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  6 in total

1.  Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.

Authors:  Takashi Miwa; Sayaka Sato; Damodar Gullipalli; Masaomi Nangaku; Wen-Chao Song
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

2.  Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury.

Authors:  Carla Q Feitoza; Patricia Semedo; Giselle M Gonçalves; Marcos A Cenedeze; Hélady S Pinheiro; Oscar Fernando Pavão Dos Santos; Richardt Gama Landgraf; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Inflamm Res       Date:  2009-08-27       Impact factor: 4.575

3.  Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy.

Authors:  Julian R Pratt; Miriam E Jones; Jun Dong; Wuding Zhou; Paramit Chowdhury; Richard A G Smith; Steven H Sacks
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

4.  Aberrant activation of the complement system in renal grafts is mediated by cold storage.

Authors:  Sorena Lo; Li Jiang; Savannah Stacks; Haixia Lin; Nirmala Parajuli
Journal:  Am J Physiol Renal Physiol       Date:  2021-05-17

Review 5.  Renal ischemia/reperfusion injury; from pathophysiology to treatment.

Authors:  Maryam Malek; Mehdi Nematbakhsh
Journal:  J Renal Inj Prev       Date:  2015-06-01

6.  Independent pathways of P-selectin and complement-mediated renal ischemia/reperfusion injury.

Authors:  Conrad A Farrar; Yi Wang; Steven H Sacks; Wuding Zhou
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.